Epigenomics 2011-08-01

Epigenetic regulation of HIV-1 transcription.

Manoj Kumar Tripathy, Wasim Abbas, Georges Herbein

Index: Epigenomics 3(4) , 487-502, (2011)

Full Text: HTML

Abstract

After entry into the target cell and reverse transcription, HIV-1 genes are integrated into the host genome. It is now well established that the viral promoter activity is directly governed by its chromatin environment. Nuc-1, a nucleosome located immediately downstream of the HIV-1 transcriptional initiation site directly impedes long-terminal repeat (LTR) activity. Epigenetic modifications and disruption of Nuc-1 are a prerequisite to the activation of LTR-driven transcription and viral expression. The compaction of chromatin and its permissiveness for transcription are directly dependent on the post-translational modifications of histones such as acetylation, methylation, phosphorylation and ubiquitination. Understanding the molecular mechanisms underlying HIV-1 transcriptional silencing and activation is thus a major challenge in the fight against AIDS and will certainly lead to new therapeutic tools.

Related Compounds

  • Chaetocin
  • Prostratin

Related Articles:

Inhibition of histone H3K9 methyltransferases by gliotoxin and related epipolythiodioxopiperazines.

2012-05-01

[J. Antibiot. 65(5) , 263-5, (2012)]

Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.

2015-01-01

[Clin. Epigenetics. 7(1) , 37, (2015)]

Epidithiodiketopiperazine as a pharmacophore for protein lysine methyltransferase G9a inhibitors: reducing cytotoxicity by structural simplification.

2013-02-01

[Bioorg. Med. Chem. Lett. 23(3) , 733-6, (2013)]

Unnatural enantiomer of chaetocin shows strong apoptosis-inducing activity through caspase-8/caspase-3 activation.

2010-09-01

[Bioorg. Med. Chem. Lett. 20(17) , 5085-8, (2010)]

Remodeling of nuclear architecture by the thiodioxoxpiperazine metabolite chaetocin.

2010-06-10

[Exp. Cell Res. 316(10) , 1662-80, (2010)]

More Articles...